Search Count: 26
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, 9MW |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, 9MW
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, 378 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, 378
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, 1T8 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, 1T8
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, 1T8 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, 1T8
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, V78 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, V78
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, V78 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, V78
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2014-12-17 Classification: HYDROLASE Ligands: CL, J3W |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: CL, J3W
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2014-12-10 Classification: HYDROLASE Ligands: CL, M17 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-10
Ligands: CL, M17
 |
Macrocyclic Transition-State Mimicking Hiv-1 Protease Inhibitors Encompassing A Tertiary Alcohol
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2014-12-10 Classification: HYDROLASE Ligands: CL, 9MW |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2014-12-10
Ligands: CL, 9MW
 |
Design And Synthesis Of P1-P3 Macrocyclic Tertiary Alcohol Comprising Hiv-1 Protease Inhibitors
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2013-11-06 Classification: HYDROLASE Ligands: CL, EQM |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-11-06
Ligands: CL, EQM
 |
Design And Synthesis Of P1-P3 Macrocyclic Tertiary Alcohol Comprising Hiv-1 Protease Inhibitors
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2013-11-06 Classification: HYDROLASE Ligands: CL, M8Y |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-11-06
Ligands: CL, M8Y
 |
Design And Synthesis Of P1-P3 Macrocyclic Tertiary Alcohol Comprising Hiv-1 Protease Inhibitors
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2013-11-06 Classification: HYDROLASE Ligands: CL, M8B |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-11-06
Ligands: CL, M8B
 |
Stereoselective Synthesis, X-Ray Analysis, And Biological Evaluation Of A New Class Of Lactam Based Hiv-1 Protease Inhibitors
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2012-11-07 Classification: HYDROLASE Ligands: UX9 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2012-11-07
Ligands: UX9
 |
Stereoselective Synthesis, X-Ray Analysis, And Biological Evaluation Of A New Class Of Lactam Based Hiv-1 Protease Inhibitors
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2012-05-09 Classification: HYDROLASE Ligands: QG8 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2012-05-09
Ligands: QG8
 |
Stereoselective Synthesis, X-Ray Analysis, And Biological Evaluation Of A New Class Of Lactam Based Hiv-1 Protease Inhibitors
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2012-05-09 Classification: HYDROLASE Ligands: QG9 |
Organism: Human immunodeficiency virus
Method: X-RAY DIFFRACTION
Release Date: 2012-05-09
Ligands: QG9
 |
Hiv-1 Inhibitors With A Tertiary-Alcohol-Containing Transition-State Mimic And Various P2 And P1 Prime Substituents
Organism: Human immunodeficiency virus 1 (z2/cdc-z34 isolate)
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2011-12-07 Classification: HYDROLASE Ligands: CXG |
Organism: Human immunodeficiency virus 1 (z2/cdc-z34 isolate)
Method: X-RAY DIFFRACTION
Release Date: 2011-12-07
Ligands: CXG
 |
Hiv-1 Inhibitors With A Tertiary-Alcohol-Containing Transition-State Mimic And Various P2 And P1 Prime Substituents
Organism: Human immunodeficiency virus 1 (z2/cdc-z34 isolate)
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2011-12-07 Classification: HYDROLASE Ligands: G40 |
Organism: Human immunodeficiency virus 1 (z2/cdc-z34 isolate)
Method: X-RAY DIFFRACTION
Release Date: 2011-12-07
Ligands: G40
 |
Hiv-1 Protease Inhibitors Containing A Tertiary Alcohol In The Transition-State Mimic With Improved Cell-Based Antiviral Activity
Organism: Human immunodeficiency virus type 1 (z2/cdc-z34 isolate)
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2009-12-15 Classification: HYDROLASE Ligands: 5AH |
Organism: Human immunodeficiency virus type 1 (z2/cdc-z34 isolate)
Method: X-RAY DIFFRACTION
Release Date: 2009-12-15
Ligands: 5AH
 |
Hiv-1 Protease Inhibitors Containing A Tertiary Alcohol In The Transition-State Mimic With Improved Cell-Based Antiviral Activity
Organism: Human immunodeficiency virus type 1 (z2/cdc-z34 isolate)
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2009-12-15 Classification: HYDROLASE Ligands: 5AH |
Organism: Human immunodeficiency virus type 1 (z2/cdc-z34 isolate)
Method: X-RAY DIFFRACTION
Release Date: 2009-12-15
Ligands: 5AH
 |
Does A Fast Nuclear Magnetic Resonance Spectroscopy- And X-Ray Crystallography Hybrid Approach Provide Reliable Structural Information Of Ligand-Protein Complexes? A Case Study Of Metalloproteinases.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2009-03-03 Classification: HYDROLASE Ligands: ZN, CA, ACT, CGS, CL, NA |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2009-03-03
Ligands: ZN, CA, ACT, CGS, CL, NA